Cybeats Technologies Corp.

Cybeats Signs Trial License with Top-5 Global Medical Device Manufacturer

by

TORONTO, May 30, 2023 /PRNewswire/ – Cybeats Technologies Corp. (“Cybeats” or the “Company”) (CSE: CYBT) (OTCQB: CYBCF) is pleased to announce a trial license agreement for SBOM Studio1 with a Top-5 global medical device company, marking its 3rd engagement from the Medical Device Manufacturing (“MDM”) Global Top-10. “The interest from yet another global leader from the … Read more

Cybeats Announces License Agreement with Starfish Medical, Canada’s Largest Contract Medical Device Design, Development and Contract Manufacturer

by

TORONTO, May 22, 2023 /PRNewswire/ – Cybeats Technologies Corp. (“Cybeats” or the “Company”) (CSE: CYBT) (OTCQB: CYBCF) is pleased to announce a license agreement for SBOM Studio with StarFish Medical1 (“StarFish”), a leading North American-based full-service medical device design company. “The interest from a prominent medical device company highlights the increasing demand for SBOM management solutions like … Read more